Hyperactivity

...ba href=/hyperactivity/a/b disorder (ADHD)."These were normal people who did not have ADHD," she says.

"Their impulsivity was not clinically significant, but it was higher than others in the study." People in the study with low blood levels of EPA and DHA were more likely than others to report experiencing symptoms of mild to moderate depression, Conklin adds."Clearly, larger studies are needed to understand the relationship between behaviour and these fats," she said.

"But by following the AHA recommendations to eat two fish meals a week people may be protecting both their hearts and their mental health." - WebMD Talk Back No comments have been posted Post your comments Related Articles No related articles were found Special Musgrave Presentation for Linton 'Kwesi' Johnson Luciano teams up with Jewish DJ sensationThe problem with change !

- - Should Portia Call An Early Election To Get Her Own Mandate?

Yes No Undecided !

- View Results Back to Top News Health Copyright© 2000-2001 Jamaica Observer.

All Rights Reserved.

Terms under which this service is provided to you.

e-Business Solutions by ...

...ba href=/hyperactivity/a/b disorder (ADHD), although they avoided stark safety warnings backed by a separate panel last month.

A committee of mostly pediatric experts urged the Food and Drug Administration to warn doctors and parents about reports linking popular stimulant drugs to aggressive behavior, manic episodes, and psychotic symptoms like hallucinations.

The reports remain rare among the estimated 2 million American children who are prescribed stimulants each month.

But experts said that events appeared often enough that parents and their doctors should be alerted so that they can discontinue the drug if such side effects arise in their children.

They recommended that warnings be included in medication guides distributed to parents along with children's prescriptions.

The recommendation was made "to be aware that this could happen and it may be a justification for stopping the drug," said Robert Nelson, a critical care specialist at the Children's Hospital of Philadelphia and the panel's chairman.

Some reports of suicidal thoughts or behaviors have also cropped up in children and adolescents taking some stimulant medications.

Those reports were most common with the Eli Lilly drug Strattera, which already carries a "black box" warning of potential suicide risk.

Suicide warnings for other drugs, including Ritalin, Concerta, and Adderall XR are not warranted at this time, the committee concluded.

The agency received hundreds of reports of aggressive behavior over the last five year...

...ba href=/hyperactivity/a/b disorder should not carry strong "black-box" warnings about potential cardiovascular and psychiatric risks.Rather, the Food and Drug Administration pediatric advisory committee recommended that the drug labels include warning language written so people can understand it.

"I wouldn't use the word 'tougher,' said panel chair Dr.

Robert Nelson, of the Children's Hospital of Philadelphia.

"'Clearer.'" By rejecting the black-box warnings in a consensus decision, the advisory panel broke with another committee that voted just last month to include them on some ADHD drugs.The FDA was poised Wednesday to follow the more recent recommendations."I think we are likely to follow them, yes," said Dr.

Robert Temple, director of the FDA's office of medical policy, following the meeting.Any updated language may not appear on labels until pharmaceutical companies begin using a recently adopted format, something that could take several years.

And the FDA may yet require black-box warnings on stimulants to treat ADHD that would alert adults to increased risk of heart attacks, strokes and other similar problems, Temple said.Nearly 3.3 million Americans age 19 and younger used an ADHD drug last year, according to Medco Health Solutions Inc., a prescription drug benefit program manager.Psychiatrists and others had urged the committee to move cautiously before recommending strengthened warnings associated with the drugs.In February, the FDA's Drug Safety and Risk Management advisory c...